- Home
- REPL vs NRDS Comparison
REPL vs NRDS Comparison
Compare REPL & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- NRDS
- Stock Information
- Founded
- REPL 2015
- NRDS 2009
- Country
- REPL United States
- NRDS United States
- Employees
- REPL N/A
- NRDS 650
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- NRDS EDP Services
- Sector
- REPL Health Care
- NRDS Technology
- Exchange
- REPL Nasdaq
- NRDS Nasdaq
- Market Cap
- REPL 578.4M
- NRDS 616.0M
- IPO Year
- REPL 2018
- NRDS 2021
- Fundamental
- Price
- REPL $8.00
- NRDS $8.54
- Analyst Decision
- REPL Strong Buy
- NRDS Buy
- Analyst Count
- REPL 6
- NRDS 5
- Target Price
- REPL $20.00
- NRDS $17.00
- AVG Volume (30 Days)
- REPL 967.9K
- NRDS 540.9K
- Earning Date
- REPL 05-15-2025
- NRDS 04-28-2025
- Dividend Yield
- REPL N/A
- NRDS N/A
- EPS Growth
- REPL N/A
- NRDS N/A
- EPS
- REPL N/A
- NRDS 0.38
- Revenue
- REPL N/A
- NRDS $687,600,000.00
- Revenue This Year
- REPL $31.16
- NRDS $12.65
- Revenue Next Year
- REPL N/A
- NRDS $8.37
- P/E Ratio
- REPL N/A
- NRDS $22.47
- Revenue Growth
- REPL N/A
- NRDS 14.71
- 52 Week Low
- REPL $4.92
- NRDS $7.55
- 52 Week High
- REPL $17.00
- NRDS $16.45
- Technical
- Relative Strength Index (RSI)
- REPL 36.82
- NRDS 43.07
- Support Level
- REPL $6.44
- NRDS $8.18
- Resistance Level
- REPL $7.97
- NRDS $8.92
- Average True Range (ATR)
- REPL 0.73
- NRDS 0.55
- MACD
- REPL 0.08
- NRDS 0.08
- Stochastic Oscillator
- REPL 41.47
- NRDS 46.26
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides onsumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.